Update on CDER, CBER, and CDRH Meetings with Industry
FDA Law Blog: Biosimilars
JUNE 8, 2023
By Philip Won & Véronique Li, Senior Medical Device Regulation Expert — On May 11, 2023, the U.S. Department of Health and Human Services declared the long-awaited end of the federal COVID-19 Public Health Emergency. The pandemic had changed the way people live, work and communicate. Such changes are not limited to personal circumstances.
Let's personalize your content